acetohexamide has been researched along with Kaposi Disease in 1 studies
Acetohexamide: A sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide.
acetohexamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is replaced by a p-acetylphenylsulfonyl group, while a hydrogen attached to the other nitrogen is replaced by a cyclohexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study of xeroderma pigmentosum has yielded unforeseen advances regarding how defects in the nucleotide excision repair pathway result in this devastating disease, but development of therapeutic strategies has trailed behind the mechanistic discoveries." | 2.61 | Novel therapeutic approaches to xeroderma pigmentosum. ( Glass, DA; Weon, JL, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weon, JL | 1 |
| Glass, DA | 1 |
1 review available for acetohexamide and Kaposi Disease
| Article | Year |
|---|---|
Novel therapeutic approaches to xeroderma pigmentosum.
Topics: Acetohexamide; Administration, Cutaneous; Animals; Caloric Restriction; Dermatology; Disease Models, | 2019 |